Tomas Vybiral is a Cardiology physician. OpenAlex indexes 14 publications with 895 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
640 Parkwood Medical Park
Elkin, NC 286212487
Telephone
336-526-7997Provider last certified this registry record 11 Oct 2023.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- PFIZER INC.Program year20251 payment
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
47.2%Beta blocker9%Metoprolol Succinate41%Metoprolol Tartrate30%Carvedilol17%Atenolol5%Propranolol Hcl3%Labetalol Hcl2%Sotalol1%Nebivolol Hcl1%Part D<11 patientsStatin7.8%Atorvastatin Calcium60%Rosuvastatin Calcium16%Simvastatin12%Pravastatin Sodium8%Lovastatin4%Part D≥302 patients+ 20 more classes in this area
Metabolism & gastrointestinal
13.9%Proton pump inhibitor5%Omeprazole49%Pantoprazole Sodium36%Esomeprazole Magnesium9%Dexlansoprazole Dr5%Lansoprazole1%Part D<11 patientsBiguanide (metformin)1.7%Metformin Hcl89%Metformin Hcl Er11%Part D≥103 patients+ 16 more classes in this area
Nervous system
11.8%SSRI2.7%Trazodone Hcl32%Sertraline Hcl30%Citalopram Hbr15%Escitalopram Oxalate11%Fluoxetine Hcl7%Paroxetine Hcl5%Part D<11 patientsGabapentinoids2.5%Gabapentin91%Pregabalin9%Part D≥150 patients+ 20 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”